FOSUN HEALTH Logo

Meningioma Causes

catalogue

Meningioma Causes

Meningioma Causes

A meningioma arises from cells in the membranes that cover the brain, and it grows where those cells are. What determines whether one appears is largely established: being female, growing older, having had radiotherapy to the head at some point in the past, and having one of a small number of inherited conditions. Those are the factors that matter. For most patients no further cause can be identified, and diet, occupation, stress and head injury have not been shown to play a part.

Where a meningioma comes from

The origin of the tumour explains both what it is and why removing it completely is often possible:

  • It arises from the arachnoid cap cells — cells within the layers of tissue that wrap around the brain and the spinal cord. These cells are present throughout the meninges, which is why meningiomas can occur almost anywhere, on the surface of the brain, at its base, within the ventricles or in the spinal canal.
  • It grows outwards from the covering, pushing the brain aside rather than infiltrating it. That is why the tumour usually has a border a surgeon can follow, and why complete removal is often achievable.
  • It brings its own blood supply, which is why tumours with a rich supply may be treated with embolisation before an operation, and why some appear very vascular on imaging.
  • It arises where the cells are, not where the risk factor was. This is the reason a tumour appears in a particular place without any local cause, and why the site cannot be predicted from anything the patient did or was exposed to.
  • It can arise in more than one place, particularly in patients with an inherited condition, which is why the whole nervous system is considered in that setting rather than only the site of the presenting tumour.

Age and sex

Two of the most consistent findings about this tumour are also the two that patients can do nothing about, and it is worth being straightforward about them:

  • It is more common in women than in men, by a margin that is consistent across populations. The reason is not fully explained, but the pattern is strong enough that hormonal factors have been studied as a possible contributor.
  • It becomes more common with age, with the frequency rising steadily through adult life. Part of this reflects genuine biology and part reflects the fact that imaging is performed more often in older people, so tumours that previously went unnoticed are now found.
  • It can occur at any adult age, and while it is uncommon in children, it does occur — particularly in the setting of an inherited condition, which is one reason a meningioma in a young person prompts a search for a syndrome.
  • Neither age nor sex is a cause in the ordinary sense. They describe who is more likely to be affected; they do not explain why an individual tumour appeared, and nothing about them changes what the treatment consists of.

Previous radiation to the head

This is the one clearly established external factor, and it is worth understanding precisely what it does and does not mean:

  • What is established — people who received radiotherapy to the head, particularly in childhood, for another condition have a higher chance of developing a meningioma years later. The association is accepted rather than debated.
  • What it does not mean — that diagnostic imaging causes meningioma. No link has been established between the doses used in CT or MRI and the development of this tumour.
  • Why it still changes practice — because it is the one exposure that can be limited. No necessary investigation should be avoided, but unnecessary examinations are not requested, and where radiotherapy to the head is required, the dose and the volume are planned to limit the exposure of normal tissue.
  • When it matters to the plan — a patient who has had previous radiotherapy to the head is followed with that history in mind, since tumours that arise in this setting are sometimes treated differently and are watched more closely.

Inherited conditions

A small proportion of meningiomas occur in people with an inherited condition, and recognising one changes what is looked for:

  • Neurofibromatosis type 2 — the best established of the associations, in which meningiomas occur more often and often in more than one place, alongside tumours of the nerves and the spinal cord. Diagnosis brings its own surveillance programme covering the nervous system.
  • Other inherited predispositions — a small number of further conditions and gene changes, including those involving BAP1 and SMARCE1, have been reported in families with meningioma; where several relatives are affected, or where a tumour occurs at an unusually young age, a genetics referral is reasonable.
  • What it changes — surveillance of the whole nervous system rather than of one site, attention to the possibility of further tumours, and information that is relevant to relatives.
  • What it does not mean — that most meningiomas are inherited. The great majority occur in people with no family history and no identifiable syndrome, and a single relative with a meningioma raises risk only modestly.

Weight and hormonal factors

These are the associations that are most often asked about, and the honest position is that they are reported rather than established:

  • Body weight — several studies have reported a higher frequency of meningioma in people with greater body weight, and the finding is fairly consistent, but the mechanism is not established and the effect on an individual is not something that can be acted on as a preventive measure.
  • Hormonal factors — the female predominance, the occurrence of the tumour during the years of hormonal activity, and reports concerning hormone replacement therapy have all prompted study. The results are mixed and no hormonal exposure has been established as a cause.
  • What this means for a decision — nothing about treatment. No one should stop a medication they need on the basis of an association that has not been established, and any such decision belongs with the clinician who prescribed it.
  • Why the research continues — because if a hormonal influence were confirmed, it would explain the sex difference, which is the most striking unexplained feature of this tumour.

Explanations that are not supported

Several widely repeated explanations can be set aside, and doing so is useful because it redirects attention to what can be acted on:

  • Mobile phones. No increase in meningioma has been established from mobile phone use, although the question has been studied extensively because the phone is held against the head.
  • Head injury. A blow to the head does not cause a meningioma. It sometimes leads to a scan that finds one, which is a different matter and is a common source of the misunderstanding.
  • Stress, diet and supplements. None has been shown to cause this tumour, and none has been shown to prevent it. Some supplements interfere with treatment, which makes taking them without discussion a real risk rather than a neutral choice.
  • Dental X-rays and diagnostic imaging. With modern equipment and current practice the doses involved have not been established as a cause of meningioma, and the association reported in older studies relates to doses no longer used.
  • Occupational and environmental exposures. No occupation, agricultural exposure or environmental agent has been established as a cause, despite repeated studies.

Frequently Asked Questions

Did anything I did cause this tumour?

No. The factors that are established — being female, growing older, previous radiotherapy to the head, and a small number of inherited conditions — are not things a person chooses or controls. Research has reported associations with body weight and with hormonal factors, but these are not established as causes, and none of them is something you could have avoided by behaving differently. This is worth stating plainly, because the opposite belief is common. What can be done is practical and comes later: making sure the tumour is assessed properly and followed with an explicit schedule.

Does having had a CT scan increase my risk?

No link has been established between the doses used in diagnostic imaging and the development of a meningioma. The exposure that is established as a risk factor is therapeutic radiotherapy to the head, particularly in childhood, where the doses are far higher. The reasonable principle that follows is not to avoid necessary investigations, but to avoid unnecessary ones — which is a matter of clinical judgement rather than of avoiding scans altogether. If a scan has been recommended, it has been recommended because the information it provides is worth more than the very small risk involved.

Do hormones or hormone replacement therapy cause meningioma?

The female predominance and the occurrence of the tumour during the years of hormonal activity have led to extensive study, and reports concerning hormone replacement therapy have been mixed rather than consistent. No hormonal exposure has been established as a cause. The practical implication is that nobody should stop a medication they need, or avoid starting one, on the basis of an association that has not been confirmed — but that it is entirely reasonable to ask the clinician who prescribed it to weigh the question with you, and to note the discussion in your records.

Is meningioma inherited?

Usually not. The great majority of meningiomas occur in people with no family history and no identifiable syndrome, and having a single relative with a meningioma raises risk only modestly. What can be inherited is a predisposition, of which neurofibromatosis type 2 is the best established; a small number of further gene changes have been reported in families with several affected members. Where more than one close relative is affected, or where a meningioma occurs at an unusually young age, a referral to a genetics service is reasonable. Relatives do not need brain imaging simply because one person in the family has had this tumour.

Ask whether your family history changes anything

Send the pathology report with the grade, the MRI images and reports with dates, the record of any previous radiotherapy with dose and dates, and a note of any family history of tumours. Our team will return a written assessment within 48 hours of the file being complete, including whether further genetic assessment or surveillance is indicated.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*